These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 9872646
1. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S. Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646 [Abstract] [Full Text] [Related]
2. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Iino K, Sasano H, Yabuki N, Oki Y, Kikuchi A, Yoshimi T, Nagura H. Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953 [Abstract] [Full Text] [Related]
3. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [Abstract] [Full Text] [Related]
4. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry. Takehara K, Sakai H, Shono T, Irie J, Kanetake H. Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104 [Abstract] [Full Text] [Related]
5. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J, Grzebieniak Z. Anticancer Res; 2008 Feb; 28(5B):2959-65. PubMed ID: 19031940 [Abstract] [Full Text] [Related]
6. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors. Kiiveri S, Liu J, Arola J, Heikkilä P, Kuulasmaa T, Lehtonen E, Voutilainen R, Heikinheimo M. Mol Cell Endocrinol; 2005 Apr 15; 233(1-2):47-56. PubMed ID: 15767045 [Abstract] [Full Text] [Related]
7. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y. Clin Cancer Res; 2000 Oct 15; 6(10):4073-81. PubMed ID: 11051259 [Abstract] [Full Text] [Related]
8. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index. Labelle P, Kyles AE, Farver TB, De Cock HE. Vet Pathol; 2004 Sep 15; 41(5):490-7. PubMed ID: 15347821 [Abstract] [Full Text] [Related]
9. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV. Mod Pathol; 1993 Nov 15; 6(6):663-8. PubMed ID: 7508113 [Abstract] [Full Text] [Related]
10. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV. Am J Surg Pathol; 1999 Mar 15; 23(3):288-95. PubMed ID: 10078919 [Abstract] [Full Text] [Related]
11. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Ohashi Y, Sasano H, Yamaki H, Shizawa S, Shineha R, Akaishi T, Satomi S, Nagura H. Anticancer Res; 1999 Mar 15; 19(3A):1843-8. PubMed ID: 10470125 [Abstract] [Full Text] [Related]
12. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry. Suzuki T, Sasano H, Nisikawa T, Rhame J, Wilkinson DS, Nagura H. Mod Pathol; 1992 May 15; 5(3):224-31. PubMed ID: 1353877 [Abstract] [Full Text] [Related]
13. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV. Mod Pathol; 2000 Sep 15; 13(9):1014-9. PubMed ID: 11007042 [Abstract] [Full Text] [Related]
14. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Anticancer Res; 2000 Sep 15; 20(1A):337-44. PubMed ID: 10769677 [Abstract] [Full Text] [Related]
15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K, Cheale M, Coleman N, Fox SB. Clin Cancer Res; 2002 Apr 15; 8(4):1075-81. PubMed ID: 11948116 [Abstract] [Full Text] [Related]
16. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Wick MR, Cherwitz DL, McGlennen RC, Dehner LP. Am J Pathol; 1986 Feb 15; 122(2):343-52. PubMed ID: 2418689 [Abstract] [Full Text] [Related]
17. [Expression of cell cycle-regulatory proteins in squamous cell carcinoma of the esophagus]. Huang JX, Song ZX, Qian RY, Xu GW. Ai Zheng; 2003 Mar 15; 22(3):277-81. PubMed ID: 12654186 [Abstract] [Full Text] [Related]
18. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Soon PS, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL, Sidhu SB. Endocr Relat Cancer; 2009 Jun 15; 16(2):573-83. PubMed ID: 19218281 [Abstract] [Full Text] [Related]
19. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M. Hum Pathol; 2005 Jul 15; 36(7):828-37. PubMed ID: 16084954 [Abstract] [Full Text] [Related]
20. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Hepatology; 1999 Jul 15; 30(1):90-9. PubMed ID: 10385644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]